[(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate

C47H61N5O6S — CID 54607598

IUPAC[(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate
SMILESCCSCCNC(=O)[C@@]1(O)[C@H](O)[C@]2(CC)C=CCN3CC[C@@]4(c5cc([C@@]6(OC(C)=O)C[C@H]7C=C(CC)CN(CCc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@@H]14)[C@@H]32
InChIInChI=1S/C47H61N5O6S/c1-7-30-23-31-26-46(58-29(4)53,39-33(15-20-51(27-30)28-31)32-13-10-11-14-36(32)49-39)35-24-34-37(25-38(35)57-6)50(5)41-45(34)17-21-52-19-12-16-44(8-2,40(45)52)42(54)47(41,56)43(55)48-18-22-59-9-3/h10-14,16,23-25,31,40-42,49,54,56H,7-9,15,17-22,26-28H2,1-6H3,(H,48,55)/t31-,40+,41-,42-,44-,45-,46+,47+/m1/s1
InChIKeyABEKLFVFUGUJFX-MGYRHACJSA-N
MW824.10 g/mol
LogP5.27
Rot. Bonds10

About [(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate

[(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate (PubChem CID 54607598) has the molecular formula C47H61N5O6S and a molecular weight of 824.10 g/mol. Its IUPAC name is [(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate.

Molecular Properties

Compound Name[(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate
PubChem CID54607598
Molecular FormulaC47H61N5O6S
Molecular Weight824.10 g/mol
Exact Mass823.43
IUPAC Name[(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate
SMILESCCSCCNC(=O)[C@@]1(O)[C@H](O)[C@]2(CC)C=CCN3CC[C@@]4(c5cc([C@@]6(OC(C)=O)C[C@H]7C=C(CC)CN(CCc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@@H]14)[C@@H]32
InChIInChI=1S/C47H61N5O6S/c1-7-30-23-31-26-46(58-29(4)53,39-33(15-20-51(27-30)28-31)32-13-10-11-14-36(32)49-39)35-24-34-37(25-38(35)57-6)50(5)41-45(34)17-21-52-19-12-16-44(8-2,40(45)52)42(54)47(41,56)43(55)48-18-22-59-9-3/h10-14,16,23-25,31,40-42,49,54,56H,7-9,15,17-22,26-28H2,1-6H3,(H,48,55)/t31-,40+,41-,42-,44-,45-,46+,47+/m1/s1
InChIKeyABEKLFVFUGUJFX-MGYRHACJSA-N
XLogP5.27
TPSA130.60 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds10
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500824.10
LogP ≤ 55.27
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate?
The IUPAC name of [(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate (CID 54607598) is [(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate.
What is the SMILES notation for [(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate?
The canonical SMILES for [(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate is CCSCCNC(=O)[C@@]1(O)[C@H](O)[C@]2(CC)C=CCN3CC[C@@]4(c5cc([C@@]6(OC(C)=O)C[C@H]7C=C(CC)CN(CCc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@@H]14)[C@@H]32.
What is the InChIKey of [(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate?
The InChIKey is ABEKLFVFUGUJFX-MGYRHACJSA-N. The full InChI is InChI=1S/C47H61N5O6S/c1-7-30-23-31-26-46(58-29(4)53,39-33(15-20-51(27-30)28-31)32-13-10-11-14-36(32)49-39)35-24-34-37(25-38(35)57-6)50(5)41-45(34)17-21-52-19-12-16-44(8-2,40(45)52)42(54)47(41,56)43(55)48-18-22-59-9-3/h10-14,16,23-25,31,40-42,49,54,56H,7-9,15,17-22,26-28H2,1-6H3,(H,48,55)/t31-,40+,41-,42-,44-,45-,46+,47+/m1/s1.
What are the key properties of [(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate?
[(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate has a molecular weight of 824.10 g/mol, XLogP of 5.27, 10 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [(13S,15S)-17-ethyl-13-[(1R,9R,10S,11R,12R,19R)-12-ethyl-10-(2-ethylsulfanylethylcarbamoyl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl] acetate is sourced from PubChem (CID 54607598), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).